STAT3-IN-20 is a selective STAT3 inhibitor that binds to the SH2 domain of STAT3, inhibiting STAT3 phosphorylation, nuclear translocation, and downstream gene transcription; it exhibits antiproliferative activity against STAT3-hyperactivated DU145 and MDA-MB-231 cancer cells (IC50 = 2.97 μM and 3.26 μM, respectively); it induces cell cycle arrest and apoptosis.